Canady Life Sciences Acquires Endocontrol French Robotic Surgical Company.
13 June 2019 - Maryland, US-based life sciences company Canady Life Sciences, Inc. (a Delaware Corp.) has acquired France-based robotic company, Endocontrol to integrate medical products offerings, the company said.
Canady Life Sciences will consolidate US Medical Innovations, LLC and US Patent Innovations, LLC under its corporate umbrella in order to integrate and grow its business and products.
Terms of the transaction were not disclosed.
Endocontrol's VIKY M is used in gynecological, urological and general laparoscopic surgery. VIKY XS is used in pediatric, thoracic and laparoscopic surgery. Endocontrol's robotic systems have been sold in 15 countries worldwide (USA, Europe, Southeast, Asia, Latin America and the Middle East).
Canady said the Endocontrol acquisition will accelerate USMI's entrance into the robotic surgical market.
This acquisition will increase its Intellectual Patent Portfolio to over 195 patents and filings globally. This voice-operated technology will be used with Canady Robotic Optical Navigation System (CRONS).
CRONS will deliver our Cold Plasma Energy Beam technology for ablation of cancer at the surgical site without the use of the human hand. The Endocontrol products will be sold with the Canady SR-70 Robotic System for free-standing and hospital-based ambulatory surgical centres and hospitals.
US Medical Innovations, LLC based out of Takoma Park, MD, is a privately-held FDA registered life science, biomedical and robotic device company.
USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives.
Endocontrol designs, manufactures and markets robotic assisted solutions for mini-invasive and laparoscopic surgery. The company offers a motorised robotic endoscopic positioner for laparoscopy via voice or foot control, and an ultra-compact motorised uterus positioner for gynecologic surgery.
Buyer: Canady Life Sciences, Inc
Deal size in USD:
Type: Corporate Acquisition
Buyer advisor: , ,
Comment: Terms of the deal were not disclosed
|Printer friendly Cite/link Email Feedback|
|Publication:||M & A Navigator|
|Date:||Jun 13, 2019|
|Previous Article:||CloudBees Acquires Rollout to Strengthen Position Continuous Integration/Continuous Delivery Market.|
|Next Article:||Angeles Equity Partners Acquires Diabetic Supplies Distributor Mini Pharmacy Enterprises.|